NCT03427814 2024-10-26Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric CancerBeiGenePhase 2 Completed136 enrolled 16 charts
NCT03575065 2024-10-26Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in ChinaBeiGenePhase 2 Completed88 enrolled 17 charts